Veeva Systems Inc. (VEEV)
$
280.63
-0.37 (-0.13%)
Key metrics
Financial statements
Free cash flow per share
7.3960
Market cap
45.9 Billion
Price to sales ratio
16.0607
Debt to equity
0.0124
Current ratio
4.6049
Income quality
1.5419
Average inventory
0
ROE
0.1374
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Veeva Systems Inc. delivers cloud-based software solutions tailored for the life sciences sector across North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company reported depreciation and amortization expenses of $39,383,000.00 reflecting the wear and tear of its assets. Furthermore, it earned an interest income of $207,987,000.00 showcasing its financial investments. The EBITDA is $730,818,000.00 a key indicator of the company's operational profitability, and all financial data pertains to the fiscal year 2025. Additionally, the company incurred an interest expense of $0.00 reflecting its debt servicing obligations. Veeva offers a comprehensive Veeva Commercial Cloud suite, which encompasses a variety of software, data, and analytics solutions like Veeva customer relationship management (CRM) and Veeva Medical CRM, alongside tools such as Veeva CLM, Veeva CRM MyInsights, Veeva CRM Approved Email, Veeva CRM Engage, and Veeva Align, among others. It also provides Veeva Vault for enterprise content and data management, facilitating the management of commercial functions including sales, marketing, medical communications, and research areas such as clinical, regulatory, quality, and safety processes. The company supports clients with professional services that encompass implementation planning, project management, solution design, systems integration, and ongoing managed services, which include outsourced administration. The stock is priced at $280.63 positioning it in the higher-end market, and it boasts a high average trading volume of 1,451,715.00 indicating strong liquidity. With a mid-range market capitalization of $45,858,309,560.00 the company is a steady performer in its field. As a key player in the Medical - Healthcare Information Services industry, Veeva Systems contributes significantly to the overall market landscape and belongs to the Healthcare sector, driving innovation and growth. The diverse range of solutions offered underscores its commitment to advancing the life sciences field, making it an essential partner for organizations aiming to enhance their operational efficiencies and deliver impactful results. Veeva Systems Inc., formerly known as Verticals onDemand, Inc., has established itself since its incorporation in 2007 and continues to thrive with its headquarters in Pleasanton, California.
Investing in Veeva Systems Inc. (VEEV) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Veeva Systems Inc. stock to fluctuate between $177.41 (low) and $291.69 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-07-08, Veeva Systems Inc.'s market cap is $45,858,309,560, based on 163,412,000 outstanding shares.
Compared to Nvidia Corp, Veeva Systems Inc. has a Lower Market-Cap, indicating a difference in performance.
To buy Veeva Systems Inc. (VEEV) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for VEEV. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Revenue: $2,746,619,000 | EPS: $4.41 | Growth: 34.86%.
Visit https://www.veeva.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $343.96 (2021-08-05) | All-time low: $151.02 (2022-10-14).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Veeva Systems gains momentum as strong earnings, Vault CRM growth, and new AI tools reinforce its life sciences edge.
seekingalpha.com
Veeva Systems is executing strongly, with accelerating growth in Vault CRM migrations and robust momentum across its portfolio, supporting my continued buy rating. Crossix is a standout growth driver, expanding rapidly and delivering measurable ROI for customers, making it a high-priority investment for pharma clients. Veeva's targeted AI strategy, embedding AI agents into core workflows, positions the company for deeper integration and future monetization opportunities.
zacks.com
Veeva Systems (VEEV) reached $281 at the closing of the latest trading day, reflecting a -1.16% change compared to its last close.
zacks.com
Veeva's new AI layer in Vault boosts automation and deepens pharma reliance, sharpening its edge in life sciences tech.
zacks.com
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.com
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?
zacks.com
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
zacks.com
Veeva (VEEV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
zacks.com
After reaching an important support level, Veeva Systems (VEEV) could be a good stock pick from a technical perspective. VEEV surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.
seekingalpha.com
Veeva Systems delivered a standout quarter, raising guidance and demonstrating accelerating growth, with Crossix and the company's Commercial Cloud, overall, driving strong revenue and margin outperformance. Despite macro and competitive risks, I see Veeva's competitive position strengthening, especially as migrations to Vault CRM and new AI offerings gain traction. Veeva AI, launching in December, is poised to boost growth and productivity, supporting my increased 3-year CAGR estimate to 20% and justifying the premium valuation.
See all news